More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

We’re still in the early stages of RSV season, but doctors are already worried about a rise in cases. As we head into the peak of 2025 RSV season, parents are once again facing an uptick in cases, ...

Norovirus cases in England's hospitals have reached their highest level this winter, with 898 patients currently receiving treatment for the illness. The latest NHS England data shows a concerning 15 ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load. The Japanese ...

The UKHSA is behind the new warning as a raft of illnesses, including flu, COVID, RSV, norovirus and hMPV, spread across the ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

But the percentage of people testing positive for HMPV out of those visiting participating GPs with symptoms of respiratory illness increased to 4.92 per cent by the middle of January 2025. This is ...